Novo Nordisk A/S Company Profile (NYSE:NVO)

Analyst Ratings

Consensus Ratings for Novo Nordisk A/S (NYSE:NVO) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $56.00 (0.67% upside)

Analysts' Ratings History for Novo Nordisk A/S (NYSE:NVO)
Show:
DateFirmActionRatingPrice TargetActions
6/28/2016Goldman Sachs Group Inc.DowngradeConviction-Buy -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2016Oddo SecuritiesUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/21/2015SwedbankUpgradeStrong-BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2015Leerink SwannInitiated CoverageMarket Perform$56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015Main First Bank AGDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2015HSBCInitiated CoverageReduceView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015Morgan StanleyUpgradeEqual Weight -> OverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2015Societe GeneraleInitiated CoverageSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015Bryan, Garnier & CoDowngradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Commerzbank AGDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/25/2014BNP ParibasInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Novo Nordisk A/S (NYSE:NVO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
4/29/2016Q1$0.53$0.57ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q3$0.47$0.48ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215$3.31$3.23$3.98 billion$27.06 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q1$3.20$3.02$25.13 billion$25.20 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015Q4$2.48$0.38$24.67 billion$24.59 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q3$2.45$2.47$22.25 billion$22.25 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q2$2.60$0.48$21.86 billion$21.63 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q1$2.37$2.43$20.83 billion$20.30 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2014Q413$0.42ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013Q1$12.11$2.20$21.04 billion$20.51 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q1$11.97$12.45$21.09 billion$21.38 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013$10.67$10.98$19.73 billion$19.98 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013$9.77$10.53$20.83 billion$20.96 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2012Q312$9.43$10.33$57.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Novo Nordisk A/S (NYSE:NVO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.39$0.53$0.48
Q2 20162$0.57$0.58$0.58
Q3 20163$0.44$0.57$0.52
Q4 20163$0.46$0.60$0.55
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Novo Nordisk A/S (NYSE:NVO)
Annual Dividend:$0.70
Dividend Yield:1.26%
Payout Ratio:35.18% (Based on Trailing 12 Months of Earnings)
30.43% (Based on Current Year Consensus EPS Estimate)
27.34% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:13.30% (3 Year Average)

Dividend History for Novo Nordisk A/S (NYSE:NVO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
2/16/2016Annual$0.703/18/20163/22/20163/30/2016Tweet This Announcement  Share This Announcement on StockTwits
3/17/2014annual$0.841.83%3/21/20143/25/20144/2/2014Tweet This Announcement  Share This Announcement on StockTwits
2/27/2013annual$3.181.81%3/21/20133/25/20134/2/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Novo Nordisk A/S (NYSE:NVO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/18/2015Richmond Partners Master LimitInsiderSell24,900$1.28$31,876.98Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Novo Nordisk A/S (NYSE:NVO)
DateHeadline
07/22/16 08:30 AMNovo Nordisk A/S (NYSE:NVO): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 08:30 AMToday's Top Gainers in the Market Novo Nordisk A/S (NYSE:NVO) from Healthcare - The Daily Leicester
07/20/16 06:18 PMShares of Novo Nordisk A/S (NVO) Rally 1.04% - Trade Calls
07/19/16 05:41 PMStock Focus: Following Analyst Expectations on Shares of Novo Nordisk A/S (NYSE:NVO) - TGP
07/19/16 05:41 PMEquity Roundup: Stock Performance Focus on Novo Nordisk A/S (NYSE:NVO) - Press Telegraph
07/19/16 05:41 PMLong Term Value Play: Novo Nordisk A/S (NYSE:NVO) - TGP
07/18/16 05:40 PMAnalyst Target and Average Rating Watch: Novo Nordisk A/S (NYSE:NVO) - Press Telegraph
07/18/16 05:40 PMAnalysts Pounding the Table on Shares of Novo Nordisk A/S (NYSE:NVO) - TGP
07/15/16 10:27 AMNovo Nordisk A/S (NYSE:NVO) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 10:27 AMLast Analysts Rating Review: Sage Therapeutics, Inc. (NASDAQ:SAGE) , Novo Nordisk A/S (NYSE:NVO) - Street Updates
07/15/16 10:27 AMLarge Inflow of Money Detected in Novo Nordisk A/S - TheFounders Daily
07/12/16 05:49 PMTrading Performance and Target Watch for Novo Nordisk A/S (NYSE:NVO) - Press Telegraph
07/12/16 02:03 AMNovo Nordisk to present 28 abstracts at the World Federation of Hemophilia Congress - [at noodls] - Press release This material is intended for global medical media only. For journalistic assessment and preparation before publication. ... This is an abstract of the original noodl. To continue reading ...
07/11/16 11:02 AM12:02 pm Novo Nordisk A/S to present 28 abstracts at the World Federation of Hemophilia Congress (July 24-28) -
07/11/16 05:53 AMNovo Nordisk A/S - Share repurchase programme - [at noodls] - company announcement Bagsværd, Denmark, 11 July 2016 - On 29 April 2016, Novo Nordisk initiated a share repurchase programme under the provisions of the European Commission's regulation no. 2273/2003 of ...
07/09/16 08:47 AMNovo Nordisk A/S (NYSE:NVO) Current Analyst Ratings - Fiscal Standard
07/08/16 05:38 PMBullish Two Hundred Day Moving Average Cross - NVO
07/07/16 05:34 PMCan Novo Nordisk A/S (NYSE:NVO) Improve on the Earnings Front? - Engelwood Daily
07/07/16 05:34 PMHow has Novo Nordisk A/S:(NYSE:NVO) performed recently? - The Daily Leicester
07/06/16 10:09 AMStock on Analyst's Buy List: Novo Nordisk A/S (NYSE:NVO) - Telanagana Press
07/06/16 10:09 AMLong Term Growth Stock: Novo Nordisk A/S (NYSE:NVO) - Telanagana Press
07/06/16 10:09 AMProfitable Stock With Upside: Novo Nordisk A/S (NYSE:NVO) - Telanagana Press
07/04/16 04:52 PMMega Cap End of Session Update: Novo Nordisk A/S (NYSE:NVO) - Telanagana Press
07/04/16 04:52 PMLarge Cap Drug Manufacturers – Other: Novo Nordisk A/S (NYSE:NVO) - Twin County News
07/04/16 06:01 AMNovo Nordisk invests DKK 400 million in an expanded production plant in Kalundborg - [at noodls] - Novo Nordisk invests DKK 400 million in an expanded production plant in Kalundborg The text version of this document is not available at the moment. The original content was posted at original link . Novo ...
07/01/16 05:33 PMRecently Issued Stock Ratings For Novo Nordisk A/S (NYSE:NVO) - Fiscal Standard
07/01/16 05:33 PMNovo Nordisk A/S (NYSE:NVO) from Drug Manufacturers – Other – Todays Top Gains - Twin County News
07/01/16 05:41 AMStatus regarding Novo Nordisk's holding of its own shares (30 June 2016) - [at noodls] - company announcement Bagsværd, Denmark, 1 July 2016 - In continuation of the company's announcements dated 3 February 2016 and 29 April 2016 concerning planned share repurchase programmes, and pursuant ...
06/30/16 05:50 PMNovo Nordisk A/S (NYSE:NVO) Earnings Glance and Target Price Review - Engelwood Daily
06/30/16 03:06 PMWhat Are Analysts Thinking about Novo Nordisk? -
06/30/16 08:25 AMNovo Nordisk A/S (NYSE:NVO) Updated Price Targets - FTSE News
06/30/16 08:20 AMIs $2.8 Billion Just The Beginning For This Novo Nordisk Diabetes Drug? -
06/29/16 08:07 AMWhy Market Share for Novo Nordisk’s Tresiba Is Set to Grow -
06/27/16 05:27 PMAs Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs
06/27/16 07:58 AMResearch Report Initiated on Select Drug Manufacturers Equities -
06/23/16 06:03 PMHC Stocks Momentum: Novo Nordisk A/S (ADR) (NYSE:NVO), St. Jude Medical, Inc. (NYSE:STJ) - share market updates (press release)
06/23/16 06:03 PMRecommendation Trends for: Novo Nordisk A/S (NYSE:NVO) - News Oracle
06/22/16 10:17 AMNovo Nordisk A/S (NYSE:NVO) Analyst Rating Consensus - TheFounders Daily
06/20/16 07:38 AMWhat Is It About Novo Nordisk's Diabetes Drug That Makes It a Top Seller? -
06/20/16 07:11 AMNovo Nordisk A/S (NYSE:NVO) headlining after earnings
06/20/16 07:09 AMNovo Nordisk A/S - aktietilbagekøbsprogram - [at noodls] - Information about cookies A cookie is a small text file, which is placed on your computer or other device. It makes it possible for us to recognize your computer and gather information about which pages ...
06/17/16 05:23 PMLarge Inflow of Money Witnessed in Novo Nordisk A/S
06/17/16 05:23 PMStock in the Spotlight: Novo Nordisk A/S (NYSE:NVO)
06/17/16 08:20 AMEarnings Expectations Overview: Novo Nordisk A/S (NYSE:NVO), The Dow Chemical Company (NYSE:DOW) - Beacon Chronicle
06/16/16 05:33 PMWhy This Pharma Giant Lost $8 Billion in Market Cap This Week -
06/16/16 09:46 AMNovo-Nordisk is Oversold
06/15/16 05:31 PMNovo Nordisk A/S (ADR) (NYSE:NVO) Victoza Reduces Cardiovascular Risks - Market Exclusive
06/15/16 02:17 PMNovo Nordisk (NVO) Reports Positive Trial Results on Victoza -
06/15/16 10:07 AMOne should look at these two Stocks: Novo Nordisk A/S (NYSE:NVO), CF Industries Holdings, Inc. (NYSE:CF) - Beacon Chronicle
06/15/16 10:07 AMTrade-Ideas: Novo Nordisk A/S (NVO) Is Today's Pre-Market Mover With Heavy Volume Stock - TheStreet.com

Social

About Novo Nordisk A/S

Novo Nordisk A/S logoNovo Nordisk A/S is a healthcare company. The Company is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. It has a range of diabetes product portfolio, including a portfolio of modern insulins as well as a human once-daily GLP-1 analog. It operates in two segments: diabetes care and biopharmaceuticals. The Company's diabetes care segment covers insulins, GLP-1, other protein-related products (such as glucagon, protein-related delivery systems and needles), oral anti-diabetic drugs and obesity. Its biopharmaceuticals segment covers the therapy areas of haemophilia care, growth hormone therapy and hormone replacement therapy. The primary production facilities owned by the Company are located at a number of sites in Denmark, and internationally in the United States, France, China and Brazil.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: NVO
  • CUSIP:
Key Metrics:
  • Previous Close: $55.63
  • 50 Day Moving Average: $54.18
  • 200 Day Moving Average: $54.28
  • P/E Ratio: 27.75
  • P/E Growth: 1.98
  • Market Cap: $141.54B
  • Beta: 0.8
  • Current Year EPS Consensus Estimate: $2.3 EPS
  • Next Year EPS Consensus Estimate: $2.56 EPS
Additional Links:
Novo Nordisk A/S (NYSE:NVO) Chart for Sunday, July, 24, 2016